mRNA Vaccines
Ideology Over Evidence: RFK Jr. Just Set Vaccine Science Back a Decade
David Alvaro, Ph.D.
Pharma's Almanac
PAO-08-25-NI-05Aug 06, 2025
Continuous
Novel Integration of Process Analytical Technologies for Continuous Biomanufacturing
Edita Botonjic-Sehic, Ph.D.
ReciBioPharm
PAO-07-25-CL-05Aug 06, 2025
Oral RNA
Unlocking Oral RNA Therapeutics: Overcoming Barriers to Gut-Stable Delivery
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-25-NI-08Jul 18, 2025
Nanoparticles
How DIANT Pharma is Transforming Nanoparticle Manufacturing
Antonio Costa, Ph.D.
DIANT Pharma
PAO-04-24-PHEX-26Jul 02, 2025
Nanoscale
Addressing Drug Delivery Challenges at the Nanoscale
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-25-NI-07Jun 16, 2025
RNA Editing
Rewriting the Script: The Past, Present, and Future of RNA Editing Therapeutics
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-25-NI-09Apr 18, 2025
Multispecific Abs
Strategic Biomanufacturing Partner for Multispecific Antibodies
Jina Kim; Busol Park; Youngsun Kim
Samsung Biologics
PAO-04-25-CL-04Apr 14, 2025
RNA
Is mRNA a Gene Therapy? Unpacking the Evolving Regulatory Debate
Cynthia A. Challener, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
PAO-03-25-NI-06Mar 26, 2025
RNA
What new opportunities are emerging for mRNA technology, and how is the portfolio of applications expanding beyond vaccines?
Pharma's Almanac
PAO-03-25-RT-02Mar 26, 2025
RNA
Beyond mRNA Vaccines: The Expanding World of RNA-Based Therapeutics
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-24Mar 21, 2025
xRNA
Revolutionizing xRNA Production: The Economic Case for Continuous Manufacturing
Aaron B. Cowley, Ph.D.
ReciBioPharm
PAO-02-25-CL-11Feb 13, 2025
RNA
Enabling Cost-Effective, Rapid Access to RNA Vaccines and Therapeutics with Enzymatically Generated z- dbDNA
Lisa Caproni
Touchlight
PAO-01-25-CL-08Feb 10, 2025
Advanced Therapies
Ensuring Nuclease Free Process Consumables for Biopharma Applications
Richard Fry
Sanisure
PAO-01-25-CL-05Jan 22, 2025
Sustainability
Synthetic DNA Delivers a Sustainable Future for Genetic Medicines
Touchlight
PAO-01-25-CL-04Jan 07, 2025
RNA
Screening T7 Polymerases to Optimize xRNA Yield and Quality
Jing Zhu, Ph.D.
ReciBioPharm
PAO-01-25-CL-02Jan 07, 2025
RNA
Lexogen launches Streamlined, Large-scale RNA-Seq Service for Blood Samples
Lexogen
PR-11-24-NI-99Nov 15, 2024
Biomanufacturing
Transforming xRNA Manufacturing with Digital Technologies and Continuous Processing
Aaron B. Cowley, Ph.D.
ReciBioPharm
PAO-11-24-CL-04Nov 11, 2024
Advanced Therapies
A New Vision for Progressing Advanced Therapies
Nathaniel Youndt
ReciBioPharm
PAO-10-24-CL-13Oct 25, 2024
Large Molecule
Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis
Waters Corporation
PR-10-24-NI-38Oct 11, 2024
RNA
Optimized Residual dsRNA Detection for mRNA Therapeutics
Eunseo (Ency) Lee, Ph.D; Namhyun Kim; Hwanjun Yoon, Ph.D.; Sukhwan Kim; Ahyeon Hwang
Samsung Biologics
PAO-09-24-CL-07Sep 30, 2024